The GLP2R is the target of the medication teduglutide, a GLP2 analog used in pediatric and adult patients with intestinal failure secondary to short bowel syndrome,2 yet much remains unknown about the in vivo function of this receptor outside of mouse models. The gene discussed is GCG; the disease is short bowel syndrome.